Carcinotech provides comprehensive solid tumor research services to advance drug development and enhance personalized therapy decisions. At the heart of its offerings is the proprietary Carcino3D™ bioprinting technology, which creates assay-ready, 3D tumors derived from patient biopsies. This innovative, translational approach delivers a predictive in vitro model, generating critical insights into therapeutic efficacy, and treatment optimization.

Biotechnology

Health Care

Life Sciences

Therapeutics

Carcinotech

Carcinotech's headquarters in Edinburgh, United Kingdom

Description

People

Jobs